Zobrazeno 1 - 10 of 49 pro vyhledávání: '"Michael S. Gottlieb"'
1
Safety and Efficacy of Enfuvirtide in Combination with Darunavir-Ritonavir and an Optimized Background Regimen in Treatment-Experienced Human Immunodeficiency Virus-Infected Patients: the Below the Level of Quantification Study
Autor: Joseph C. Gathe, Andrew R. Zolopa, Michael S. Gottlieb, Edwin DeJesus, Michael L. Greenberg, Carol Jean Guittari
Publikováno v: Antimicrobial Agents and Chemotherapy. 52:4315-4319
Enfuvirtide is the first fusion and entry inhibitor approved for use for the treatment of human immunodeficiency virus (HIV) type 1 infection and as such represents a novel class of agents. For the population of patients experienced with three antire
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bded6113bf4a9fc5a3f2cddb70b64a4
https://doi.org/10.1128/aac.00467-08
Zobrazit plný text záznamu
5
AIDS — Past and Future
Autor: Michael S. Gottlieb
Publikováno v: New England Journal of Medicine. 344:1788-1791
Do not fear to repeat what has already been said. Men need the truth dinned into their ears many times and from all sides. The first rumor makes them prick up their ears, the second registers, and the third enters. Rene Theophile Hyacinthe Laennec (1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d4c5c65633ca4731645faeeee29b430
https://doi.org/10.1056/nejm200106073442312
Zobrazit plný text záznamu
6
Efficacy, safety, and tolerability of etravirine with and without darunavir/ritonavir or raltegravir in treatment-experienced patients: analysis of the etravirine early access program in the United States
Autor: Michael Sension, Michael S. Gottlieb, Michael Wohlfeiler, Annemie Hoogstoel, Jonathan S Appelbaum, Steven Nijs, William J. Towner, Paul Bellman, Rodica Van Solingen-Ristea, Joseph Gathe, Robert Ryan, Jacob Lalezari, James Witek
Publikováno v: Journal of acquired immune deficiency syndromes (1999). 53(5)
Etravirine, a nonnucleoside reverse transcriptase inhibitor, was provided through an international early access program (EAP) prior to regulatory approval.The Phase III, nonrandomized, open-label EAP investigated etravirine 200 mg twice daily plus a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::236e8c627c50a32e7598538837be698b
https://pubmed.ncbi.nlm.nih.gov/20134329
Zobrazit plný text záznamu
7
Cytomegalovirus Retinopathy as the Initial Manifestation of the Acquired Immunodeficiency Syndrome
Autor: Lesley J. MacArthur, Gary N. Holland, Rebecca F. Sison, Michael S. Gottlieb, Noel C. Wheeler
Publikováno v: American Journal of Ophthalmology. 112:243-249
Of 100 consecutive patients with human immunodeficiency virus infection and cytomegalovirus retinopathy, 15 did not have a previous diagnosis of the acquired immunodeficiency syndrome before the ocular infection. All had other HIV-related disorders t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38907651fd7fc7d86dd9b3c1f2cd162d
https://doi.org/10.1016/s0002-9394(14)76724-8
Zobrazit plný text záznamu
10
Treatment guidelines for HIV-associated wasting
Autor: Bruce Polsky, Patrick M. Nemechek, Michael S. Gottlieb
Publikováno v: Mayo Clinic proceedings. 75(4)
Patients with acquired immunodeficiency syndrome (AIDS) often suffer from weight loss manifested by a loss of body cell mass (BCM). The causes of human immunodeficiency virus (HIV)-associated wasting may include anorexia, malabsorption, and a variety
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cb1088b72f6a690d99e4d03bd9c9cb3
https://pubmed.ncbi.nlm.nih.gov/10761494
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje